|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 58.50 GBX | 0.00% |
|
-20.95% | -20.41% |
| Jan. 10 | Arecor Therapeutics shares tumble as plans Tetris wind-down | AN |
| Jan. 10 | Arecor Therapeutics to Shutter Tetris Pharma Unit; Ends License Deal with Xeris | MT |
Executive Committee: Arecor Therapeutics plc
| Manager | Positions heldSince | ||||
|---|---|---|---|---|---|
![Sarah Howell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>) Sarah Howell 50 year |
| ||||
Jan Jezek |
| ||||
Fiona Lawrence |
| ||||
David J. Ellam |
|
Composition of the Board of Directors: Arecor Therapeutics plc
| Director | CommitteesSince | ||||||
|---|---|---|---|---|---|---|---|
Andrew Richards 65 year |
| ||||||
Jeremy Morgan 62 year |
| ||||||
Christine Soden 67 year |
| ||||||
Mohammad Fazeli 60 year |
| ||||||
Alan Smith 79 year |
| ||||||
Sarah Howell 50 year |
|
Latest Appointments: Arecor Therapeutics plc
Former Officers and Directors: Arecor Therapeutics plc
| Insider | Positions held SinceUntil | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||
|
|
Age distribution of managers
Parity Men Women
| Male | 9 |
|---|---|
| Female | 3 |
Of which Executive Committee
| Male | 3 |
|---|---|
| Female | 1 |
Of which Directors
| Male | 5 |
|---|---|
| Female | 1 |
